3 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 5 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Acute Myeloid Leukemia With Multilineage Dysplasia: new trials by email Literature Review of Acute Myeloid Leukemia With Multilineage Dysplasia trials Research Report on Acute Myeloid Leukemia With Multilineage Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biocollection in MyeloDysplastic Syndrome (P-MDS) description of MDS pzatient cohort - Myelodysplastic Syndromes, Myelodysplastic Anemia | Not applicable | Recruiting | University Hospital, Brest | 150 | 2022-10-19 | 2026-06-25 |
| Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Liposome-encapsulated Daunorubicin-Cytarabine - Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 49 | 2022-08-24 | 2026-06-30 |
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome Azacitidine, Glutaminase Inhibitor CB-839 - Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 28 | 2017-11-15 | 2024-05-14 |
| Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Cytarabine, Vosaroxin - Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 42 | 2016-03-01 | 2025-04-15 |
| Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome tosedostat, cytarabine, decitabine - Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | Completed | Fred Hutchinson Cancer Center | 34 | 2012-05-01 | 2017-02-15 |
| Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 46 | 2010-05-19 | 2023-01-23 |
Myelodysplastic Syndromes (4) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Burkitt Lymphoma (1) · Chromosome 5q Deletion Syndrome (1) · Chromosome Aberrations (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Multiple Myeloma (1) · Myeloproliferative Disorders (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Bone Marrow Diseases (4) · Leukemia (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Leukemia, Myeloid (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Chronic Disease (2) · Disease Attributes (2) · Myelodysplastic-Myeloproliferative Diseases (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Cytarabine (3) · Azacitidine (1) · Biopsy (1) · CB-839 (1) · CPX-351 (1) · Cyclophosphamide (1) · Daunorubicin (1) · Decitabine (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Injections (1) · Liposomes (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Specimen Handling (1)
Fred Hutchinson Cancer Center (2) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · University Hospital, Brest (1) · Vanderbilt-Ingram Cancer Center (1)
United States (5) · France (1)
Courtney DiNardo (1) · John Pagel (1) · Joshua F Zeidner (1) · Michael Savona, MD (1) · Nathalie Douet-Guilbert, MD,PhD (1) · Rachel B. Salit (1) · Sanjay Mohan, MD (1)
P30CA015704 (1), P30CA068485 (1), R01CA206210 (1), UM1CA186712 (1)